Search Results

You are looking at 1 - 1 of 1 items for

  • Author: Meng-Hsing Wu x
  • Refine by access: Content accessible to me x
Clear All Modify Search
Wan-Ning Li Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan

Search for other papers by Wan-Ning Li in
Google Scholar
PubMed
Close
,
Meng-Hsing Wu Department of Physiology, National Cheng Kung University, Tainan, Taiwan
Department of Obstetrics & Gynecology, College of Medicine, National Cheng Kung University, Tainan, Taiwan

Search for other papers by Meng-Hsing Wu in
Google Scholar
PubMed
Close
, and
Shaw-Jenq Tsai Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan
Department of Physiology, National Cheng Kung University, Tainan, Taiwan

Search for other papers by Shaw-Jenq Tsai in
Google Scholar
PubMed
Close

Endometriosis is a benign gynecological disease that affects about 10% of women of reproductive age. Patients with endometriosis suffer from long-term coexistence with dysmenorrhea, dyspareunia, and even infertility, which severely reduces quality of life. So far, surgical removal and hormonal medication are the major treatment options; however, high recurrence and severe adverse effects hamper the therapeutic efficacy. Hypoxia is an inevitable cellular stress in many diseases that regulates the expression of a significant subset of genes involved in pathophysiological processes. A growing body of evidence demonstrates that hypoxia plays critical role in controlling the disease phenotypes of endometriosis, such as increasing adhesion ability, causing dysregulation of estrogen biosynthesis, aberrant production of proinflammatory cytokines, increasing angiogenic ability, and suppression of immune functions. In this review, we summarize the findings of the most recent studies in exploring the underlying mechanisms of hypoxia involved in endometriosis. Potential therapeutic options for targeting HIF and downstream effectors will also be discussed.

Free access